Erythromycin for the prevention and treatment of feeding intolerance in preterm infants

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Ng, Eugene ^a,c   Shah, Vibhuti S ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

*Gastrointestinal motility; Erythromycin adverse effects; *therapeutic use ; Gastrointestinal agents adverse effects; *therapeutic use ; Gastrointestinal diseases *drug therapy ; Infant, newborn; Infant, premature

Indexed keywords

CISAPRIDE; ERYSIL; ERYTHROMYCIN ETHYLSUCCINATE; PLACEBO; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; DEMOGRAPHY; DIARRHEA; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; EMBASE; ENTERIC FEEDING; FECES COMPOSITION; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LOOSE FECES; LOW DRUG DOSE; MEDLINE; NECROTIZING ENTEROCOLITIS; NUTRITIONAL INTOLERANCE; OUTCOME ASSESSMENT; PREMATURITY; QT PROLONGATION; REVIEW; SEPTICEMIA; SIDE EFFECT; STOOL COLONIZATION; SYSTEMATIC REVIEW; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; VOMITING; WEIGHT GAIN;

EID: 55049098016     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001815.pub2     Document Type: Review

References (43)

1. Aly 2007 {published data only} Aly H, Abdel-Hady H, Khashaba M, El-Badry N. Erythromycin and feeding intolerance in premature infants: a randomized trial. Journal of Perinatology 2007;27:39- 43.
2. Cairns 2002 {published data only} Cairns PA, Craig S, Tubman R, Roberts RS, Wilson J, Schmidt B. Randomised controlled trial of low-dose erythromycin in preterm infants with feed intolerance. Pediatric Research 2002;51:379A.
3. ElHennawy 2003 {published data only} ElHennawy AA, Sparks JW, Armentrout D, Huseby V, Berseth CL. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants. JPGN 2003;37:281-6.
4. Madani 2004 {published data only} Madani A, Pishva N, Pourarian Sh, Zarkesh M. The efficacy of oral erythromycin in enhancement ofmilk tolerance in premature infants: A randomized controlled trial. Iranian Journal of Medical Sciences 2004;29:1-4.
5. Ng PC 2001 {published data only} Ng PC, So KW, Fung KSC, Lee CH, Fok TF, Wong E, et al.Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2001;84:F177-82.
6. Ng SC 2003 {published data only} Ng SC, Gomez JM, Rajadurai VS, Saw S, Quak S. Establishing enteral feeding in preterminfants with feeing intolerance;A randomized controlled study of low-dose erythromycin. JPGN 2003;37:554-8.
7. Nuntnarumit 2006 {published data only} Nuntnarumit P, Kiatchoosakun P, Tantiprapa W, Boonkasidecha S. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants. Journal of Pediatrics 2006;148:600-5.
8. Oei 2001 {published data only} Oei J, Lui K. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants. Acta Paediatrica 2001;90:904-8.
9. Patole 2000 {published and unpublished data} Almonte R, Patole SK, Kadalraja R, Muller R, Whitehall JS. Erythromycin for feed intolerance in preterm neonate: a randomised, controlled trial. Pediatric Research 1999;45:276A.
10. * Patole SK, Almonte R, Kadalraja R, Tuladhar R, Muller R, Whitehall JS. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates?. International Journal of Clinical Practice 2000;54:504-8.
11. Stenson 1998 {published data only} * Stenson BJ, Middlemist L, Lyon AJ. Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial. Archives of Disease in Childhood 1998;79:F212-4.
12. Costalos 2001 {published data only} Costalos C, Gavrili V, Skouteri V, Gounaris A. The effect of low-dose erythromycin on whole gastrointestinal transit time of preterm infants. Early Human Development 2001;65:91-6.
13. Costalos 2002 {published data only} Costalos C, Gounaris A, Varhalama E, Kokori F, Alexiou N, Kolovou E. Erythromycin as a prokinetic agent in preterm infants. JPGN 2002;34:23-5.
14. Curry 2004 {published data only} Curry JI, Lander AD, Stringer MD. A multicenter, randomized, double-blind, placebo-controlled trial of the prokinetic agent erythromycin in the postoperative recovery of infants with gastroschisis. Journal of Pediatric Surgery 2004;39:565-9.
15. Jadcherla 2002 {published data only} Jadcherla SR, Berseth CL. Effect of erythromycin on gastroduodenal contractile activity in developing neonates. JPGN 2002;34:16-22.
16. Nogami 2001 {published data only} Nogami K, Nishikubo T, Minowa H, Uchida Y, Kamitsuji H, Takahashi Y. Intravenous low-dose erythromycin administration for infants with feeding intolerance. Pediatrics International 2001;43:605-10.
17. al Tawil 1996 al Tawil Y, Berseth CL. Gestational and postnatal maturation of duodenal motor responses to intragastric feeding. Journal of Pediatrics 1996;129:374-81.
18. Annese 1992 Annese V, Janssens J, Vantrappen G, Tack J, Peeters TL, Willemse P, Van Cutsem E. Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination. Gastroenterology 1992;102:823-8.
19. Aynsley-Green 1983 Aynsley-Green A. Hormones and postnatal adaptation to enteral nutrition. Journal of Pediatric Gastroenterology and Nutrition 1983;2:418-27.
20. Berseth 1989 Berseth CL. Gestational evolution of small intestine motility in preterm and term infants. Journal of Pediatrics 1989;115:646-51.
21. Berseth 1990 Berseth CL. Neonatal small intestinal motility: motor responses to feeding in term and preterm infants. Journal of Pediatrics 1990;117:777-82.
22. Coulie 1998 Coulie B, Tack J, Peeters T, Janssens J. Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 1998;43:395-400.
23. Di Lorenzo 1990 Di Lorenzo C, Lachman R, Hyman PE. Intravenous erythromycin for postpyloric intubation. Journal of Pediatric Gastroenterology and Nutrition 1990;11:45-7.
24. Dworkin 1976 Dworkin LD, Levine GM, Farber NJ, Spector MH. Small intestinal mass of the rat is partially determined by indirect effects of intraluminal nutrition. Gastroenterology 1976;71:626-30.
25. George 1968 George, JD. New clinical method for measuring the rate of gastric emptying: the double sampling test meal. Gut 1968;9:237-42.
26. Honein 1999 Honein A, Paulozzi LJ, Himelright M, et al.Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 1999;354:2101-5.
27. Itoh 1984a Itoh Z, Nakaya M, Suzuki T, Arai H, Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. American Journal of Physiology 1984;247:G688-94.
28. Itoh 1984b Itoh Z, Suzuki T, Nakaya M, Inoue M, Mitsuhashi S. Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut. Antimicrobial Agents and Chemotherapy 1984;26:863-9.
29. Johnson 1976 Johnson LR. The trophic action of gastrointestinal hormones. Gastroenterology 1976;70:278-88.
30. Kubota 1994 Kubota M, Nakamura T, Motokura T, Mori S, Nishida A. Erythromycin improves gastrointestinal motility in extremely low birthweight infants. Acta Paediatrica Japonica 1994;36:198-201.
31. Lewin 1996 Lewin MB, Bryant RM, Fenrich AL, Grifka RG. Cisapride-induced prolonged QT interval. Journal of Pediatrics 1996;128:279-81.
32. Lyon 1998 Lyon AJ, McColm J, Middlemist L, Fergusson S, McIntosh N, Ross PW. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 1998;78:F10-4.
33. Miller 1990 Miller SM, O'Dorisio TM, Thomas FB, Mekhjian HS. Erythromycin exerts a prokinetic effect in patients with chronic idiopathic intestinal pseudo-obstruction. Gastroenterology 1990;98:A375.
34. Ng 1997 Ng PC, Fok TF, Lee CH, Wong W, Cheung KL. Erythromycin treatment for gastrointestinal dysmotility in preterm infants. Journal of Paediatrics and Child Health 1997;33:148-50.
35. Otterson 1990 Otterson MF, Sarna SK. Gastrointestinal motor effects of erythromycin. American Journal of Physiology 1990;259:G355-63.
36. Peeters 1989 Peeters T, Matthijs G, Depoortere I, et al.Erythromycin is a motilin receptor agonist. American Journal of Physiology 1989;257:G470-4.
37. Sarna 1991 Sarna SK, Soergel KH, Koch TR, et al.Gastrointestinal motor effects of erythromycin in humans. Gastroenterology 1991;101:1488-96.
38. Simkiss 1994 Simkiss DE, Adams IP, Myrdal U, Booth IW. Erythromycin in neonatal postoperative intestinal dysmotility. Archives of Disease in Childhood 1994;71:128-9.
39. Su 1998 Su BH, Lin HC, Peng CT, Tsai CH. Effect of erythromycin on feeding intolerance in very low birth weight infants: a preliminary observation. Acta Paed Sin 1998;39:324-6.
40. Tack 1992 Tack J, Janssens J, Vantrappen G, Peeters T, Annese V, Depoortere I, Muls E, Bouillon R. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992;103:72-9.
41. Tomomasa 1985 Tomomasa T, Itoh Z, Koizumi T, Kuroume T. Nonmigrating rhythmic activity in the stomach and duodenum of neonates. Biology of the Neonate 1985;48:1-9.
42. Zara 1985 Zara GP, Thompson HH, Pilot MA, Ritchie HD. Effects of erythromycin on gastrointestinal tract motility. Journal of Antimicrobial Chemotherapy 1985;16 (Suppl A):175-9.
43. Ng 2000 Ng E, Shah V. Erythromycin for feeding intolerance in preterm infants. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD001815]